Answer
Glyxambi should not be used during breastfeeding because a risk to newborns or infants cannot be excluded; human milk-excretion data are unavailable, and animal data show excretion of empagliflozin and linagliptin into milk.
Sources for this answer
- Glyxambi 10 mg/5 mg film-coated tablets and Glyxambi 25 mg/5 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 14Document updated
Sources checked